IL84861A - Nasal pharmaceutical composition comprising human calcitonin and viscosity-increasing swelling agent - Google Patents

Nasal pharmaceutical composition comprising human calcitonin and viscosity-increasing swelling agent

Info

Publication number
IL84861A
IL84861A IL84861A IL8486187A IL84861A IL 84861 A IL84861 A IL 84861A IL 84861 A IL84861 A IL 84861A IL 8486187 A IL8486187 A IL 8486187A IL 84861 A IL84861 A IL 84861A
Authority
IL
Israel
Prior art keywords
viscosity
human calcitonin
pharmaceutical composition
swelling agent
increasing swelling
Prior art date
Application number
IL84861A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL84861A publication Critical patent/IL84861A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL84861A 1986-12-23 1987-12-17 Nasal pharmaceutical composition comprising human calcitonin and viscosity-increasing swelling agent IL84861A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH520086 1986-12-23

Publications (1)

Publication Number Publication Date
IL84861A true IL84861A (en) 1992-09-06

Family

ID=4289609

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84861A IL84861A (en) 1986-12-23 1987-12-17 Nasal pharmaceutical composition comprising human calcitonin and viscosity-increasing swelling agent

Country Status (15)

Country Link
EP (1) EP0277462B1 (ja)
JP (1) JPS63166832A (ja)
AT (1) ATE75404T1 (ja)
AU (1) AU608268B2 (ja)
CA (1) CA1322330C (ja)
DE (1) DE3778682D1 (ja)
DK (1) DK166714B1 (ja)
ES (1) ES2032303T3 (ja)
GR (1) GR3004585T3 (ja)
IL (1) IL84861A (ja)
MY (1) MY102411A (ja)
NZ (1) NZ223005A (ja)
PH (1) PH24802A (ja)
PT (1) PT86436B (ja)
ZA (1) ZA879593B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
AU638128B2 (en) * 1990-04-10 1993-06-17 University Of Melbourne, The Calcitonin gene related peptide for the treatment of undescended testicles
JPH05506223A (ja) * 1990-04-10 1993-09-16 ザ ユニバーシティー オブ メルボルン 下降睾丸の処理のためのカルシトニン遺伝子関連ペプチド
JP3179538B2 (ja) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト 安定なヒトカルシトニンの水性溶液
GB9108634D0 (en) * 1991-04-23 1991-06-12 Ciba Geigy Pharmaceutical compositions
EP0803255A4 (en) * 1994-06-03 1999-06-30 Tsumura & Co DRUG
CA2311530C (en) * 1998-01-30 2008-06-10 Novartis Consumer Health S.A. Nasal solutions
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
JP2002154989A (ja) * 2000-11-14 2002-05-28 Lion Corp 眼科用組成物、及び生体粘膜への薬物の滞留性向上組成物
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
CH657858A5 (de) * 1983-06-27 1986-09-30 Ciba Geigy Ag Substanz aus der gruppe der calcitonine.
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物

Also Published As

Publication number Publication date
DE3778682D1 (de) 1992-06-04
ES2032303T3 (es) 1993-02-01
DK676987D0 (da) 1987-12-22
AU608268B2 (en) 1991-03-28
CA1322330C (en) 1993-09-21
ATE75404T1 (de) 1992-05-15
EP0277462B1 (de) 1992-04-29
ZA879593B (en) 1988-06-22
MY102411A (en) 1992-06-17
PT86436B (pt) 1990-11-20
NZ223005A (en) 1990-07-26
DK676987A (da) 1988-06-24
EP0277462A1 (de) 1988-08-10
GR3004585T3 (ja) 1993-04-28
JPS63166832A (ja) 1988-07-11
AU8295587A (en) 1988-06-23
DK166714B1 (da) 1993-07-05
PT86436A (en) 1988-01-01
PH24802A (en) 1990-10-30

Similar Documents

Publication Publication Date Title
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DE3875025D1 (de) Calcitonin enthaltende zusammensetzung fuer die nasale verabreichung.
NZ295211A (en) Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
EP0508488A3 (en) Use of inositol triphosphate for the treatment of diseases associated with metal intoxications
SE8305485L (sv) Galeniska kompositioner innefattande kalcitonin och deras anvendning
IL84861A (en) Nasal pharmaceutical composition comprising human calcitonin and viscosity-increasing swelling agent
MY101784A (en) Novel pharmacological compounds
IL74446A0 (en) Topical pharmaceutical compositions
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
GB1506664A (en) Antiviral compositions
GB2021409A (en) Pharmaceutical composition
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
IL76458A0 (en) Polyether ionophore,its preparation and pharmaceutical and veterinary preparations containing it
ES2029161A6 (es) Procedimiento para la preparacion de composiciones de carbocisteinato de zinc.